SK26995A3 - Single acetamides for suppressing of diseases method of their production and their using for production of medicines pharmaceutical agents on their base and method of their production - Google Patents
Single acetamides for suppressing of diseases method of their production and their using for production of medicines pharmaceutical agents on their base and method of their production Download PDFInfo
- Publication number
- SK26995A3 SK26995A3 SK269-95A SK26995A SK26995A3 SK 26995 A3 SK26995 A3 SK 26995A3 SK 26995 A SK26995 A SK 26995A SK 26995 A3 SK26995 A3 SK 26995A3
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- methyl
- dihydro
- acetamide
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4407047A DE4407047A1 (de) | 1994-03-03 | 1994-03-03 | Acetamide |
Publications (1)
Publication Number | Publication Date |
---|---|
SK26995A3 true SK26995A3 (en) | 1995-10-11 |
Family
ID=6511754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK269-95A SK26995A3 (en) | 1994-03-03 | 1995-03-01 | Single acetamides for suppressing of diseases method of their production and their using for production of medicines pharmaceutical agents on their base and method of their production |
Country Status (16)
Country | Link |
---|---|
US (1) | US5472961A (no) |
EP (1) | EP0670318A3 (no) |
JP (1) | JPH07267949A (no) |
KR (1) | KR950032152A (no) |
CN (1) | CN1121072A (no) |
AU (1) | AU682242B2 (no) |
CA (1) | CA2143691A1 (no) |
CZ (1) | CZ54095A3 (no) |
DE (1) | DE4407047A1 (no) |
HU (1) | HUT73656A (no) |
MX (1) | MX9501157A (no) |
NO (1) | NO950813L (no) |
PL (1) | PL307503A1 (no) |
RU (1) | RU95103105A (no) |
SK (1) | SK26995A3 (no) |
ZA (1) | ZA951744B (no) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002212970B2 (en) * | 2000-09-15 | 2007-05-31 | The Scripps Research Institute | Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
US6992193B2 (en) | 2003-06-10 | 2006-01-31 | Adolor Corporation | Sulfonylamino phenylacetamide derivatives and methods of their use |
JP4060247B2 (ja) * | 2003-07-14 | 2008-03-12 | 株式会社大塚製薬工場 | 薬剤容器用の口部材 |
WO2005046687A1 (en) * | 2003-10-30 | 2005-05-26 | Tioga Pharmaceuticals, Inc. | Use of selective opiate receptor modulators in the treatment of neuropathy |
KR101799429B1 (ko) * | 2010-05-03 | 2017-11-21 | 에스케이바이오팜 주식회사 | 신경 세포 사멸 또는 신경 퇴화를 억제하기 위한 약학적 조성물 |
KR101773331B1 (ko) * | 2012-03-05 | 2017-08-31 | 닥터 레디스 레보러터리즈 리미티드 | 카파 오피오이드 수용체(κor) 작용제인 치환된 헤테로시클릭 아세트아미드 |
LT2861566T (lt) | 2012-06-13 | 2017-02-10 | F. Hoffmann-La Roche Ag | Nauji diazaspirocikloalkanai ir azaspirocikloalkanai |
CA2878442A1 (en) | 2012-09-25 | 2014-04-03 | F. Hoffmann-La Roche Ag | Hexahydropyrrolo[3,4-c]pyrrole derivatives and related compounds as autotaxin (atx) inhibitors and as inhibitors of the lysophosphatidic acid (lpa) production for treating e.g. renal diseases |
AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
SI3074400T1 (en) | 2013-11-26 | 2018-03-30 | F. Hoffmann-La Roche Ag | Octahydro-cyclobut (1,2-c, 3,4-cy) dipyrrole derivatives as autoantaxine inhibitors |
UA118582C2 (uk) | 2014-03-26 | 2019-02-11 | Ф. Хоффманн-Ля Рош Аг | Біциклічні сполуки як інгібітори продукції аутотаксину (atx) і лізофосфатидилової кислоти (lpa) |
CN106029667B (zh) | 2014-03-26 | 2019-08-23 | 豪夫迈·罗氏有限公司 | 作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的稠合[1,4]二氮杂*化合物 |
MA41179A (fr) | 2014-12-19 | 2017-10-24 | Cancer Research Tech Ltd | Composés inhibiteurs de parg |
MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
MX2020004504A (es) | 2015-09-04 | 2021-11-10 | Hoffmann La Roche | Derivados de fenoximetilo. |
MX2017015034A (es) | 2015-09-24 | 2018-04-13 | Hoffmann La Roche | Nuevos compuestos biciclicos como inhibidores duales de autotaxina (atx)/anhidrasa carbonica (ca). |
JP6846414B2 (ja) | 2015-09-24 | 2021-03-24 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Atx阻害剤としての二環式化合物 |
BR112018006080A2 (pt) | 2015-09-24 | 2018-10-09 | F. Hoffmann-La Roche Ag | novos compostos bicíclicos como inibidores de dupla ação de atx/ca |
CA2991615A1 (en) | 2015-09-24 | 2017-03-30 | F. Hoffmann-La Roche Ag | Bicyclic compounds as atx inhibitors |
WO2018167001A1 (en) | 2017-03-16 | 2018-09-20 | F. Hoffmann-La Roche Ag | Heterocyclic compounds useful as dual atx/ca inhibitors |
CN110382484B (zh) | 2017-03-16 | 2022-12-06 | 豪夫迈·罗氏有限公司 | 新的作为atx抑制剂的二环化合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4192883A (en) * | 1976-04-09 | 1980-03-11 | Pierre Fabre, S.A. | Amides of pyrrolidinoethylamine which can be used in lung therapy |
GB8618188D0 (en) * | 1986-07-25 | 1986-09-03 | Ici Plc | Diamine compounds |
GB8827479D0 (en) * | 1988-11-24 | 1988-12-29 | Zambeletti Spa L | Novel compounds |
DE3935371A1 (de) * | 1988-12-23 | 1990-07-05 | Merck Patent Gmbh | Stickstoffhaltige ringverbindungen |
JPH05501551A (ja) * | 1989-11-24 | 1993-03-25 | スミスクライン ビーチャム ファルマシューティッチ エッセ ピ ア | アザ環式誘導体 |
DE4215213A1 (de) * | 1992-05-09 | 1993-11-11 | Merck Patent Gmbh | Arylacetamide |
-
1994
- 1994-03-03 DE DE4407047A patent/DE4407047A1/de not_active Withdrawn
-
1995
- 1995-02-18 EP EP95102310A patent/EP0670318A3/de not_active Withdrawn
- 1995-02-28 AU AU13540/95A patent/AU682242B2/en not_active Ceased
- 1995-03-01 CN CN95100028A patent/CN1121072A/zh active Pending
- 1995-03-01 MX MX9501157A patent/MX9501157A/es unknown
- 1995-03-01 CZ CZ95540A patent/CZ54095A3/cs unknown
- 1995-03-01 CA CA002143691A patent/CA2143691A1/en not_active Abandoned
- 1995-03-01 SK SK269-95A patent/SK26995A3/sk unknown
- 1995-03-02 ZA ZA951744A patent/ZA951744B/xx unknown
- 1995-03-02 RU RU95103105/04A patent/RU95103105A/ru unknown
- 1995-03-02 US US08/397,758 patent/US5472961A/en not_active Expired - Fee Related
- 1995-03-02 NO NO950813A patent/NO950813L/no unknown
- 1995-03-02 PL PL95307503A patent/PL307503A1/xx unknown
- 1995-03-02 KR KR1019950004262A patent/KR950032152A/ko not_active Application Discontinuation
- 1995-03-03 JP JP7044587A patent/JPH07267949A/ja active Pending
- 1995-03-03 HU HU9500662A patent/HUT73656A/hu unknown
Also Published As
Publication number | Publication date |
---|---|
NO950813L (no) | 1995-09-04 |
JPH07267949A (ja) | 1995-10-17 |
DE4407047A1 (de) | 1995-09-07 |
CN1121072A (zh) | 1996-04-24 |
HU9500662D0 (en) | 1995-04-28 |
RU95103105A (ru) | 1997-01-10 |
PL307503A1 (en) | 1995-09-04 |
HUT73656A (en) | 1996-09-30 |
US5472961A (en) | 1995-12-05 |
EP0670318A3 (de) | 1996-03-06 |
NO950813D0 (no) | 1995-03-02 |
EP0670318A2 (de) | 1995-09-06 |
ZA951744B (en) | 1995-12-08 |
AU682242B2 (en) | 1997-09-25 |
AU1354095A (en) | 1995-09-14 |
KR950032152A (ko) | 1995-12-20 |
MX9501157A (es) | 1997-02-28 |
CZ54095A3 (en) | 1995-11-15 |
CA2143691A1 (en) | 1995-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK26995A3 (en) | Single acetamides for suppressing of diseases method of their production and their using for production of medicines pharmaceutical agents on their base and method of their production | |
US5532266A (en) | Acrylacetamides | |
KR870000354B1 (ko) | 피리딘-2-에테르 또는 피리딘-2-티오에테르의 제조방법 | |
DE60127863T2 (de) | Phenylderivate | |
KR101034961B1 (ko) | 당뇨병의 치료를 위한 헤테로바이사이클릭 설폰아마이드 유도체 | |
SK282476B6 (sk) | Derivát benzylpiperidínu, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje | |
NO171017B (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive cykliske aminderivater | |
CS201040B2 (en) | Method of producing etherified hydroxy-benzo-diheterocyclic compounds | |
SK48696A3 (en) | Benzofuran derivative, preparation method thereof and pharmaceutical composition containing its | |
SK281457B6 (sk) | 3-[4-(4-(4-kyánfenyl)-1-piperazinyl)butyl]-5-kyánindol, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje | |
SK50895A3 (en) | 3-indolylpiperidine derivative, method of its preparation, its use for preparation of pharmaceutical composition and pharmaceutical composition containing them | |
SK13692000A3 (sk) | Derivát 1-(3-heteroarylpropyl- alebo -prop-2-enyl)-4-benzylpiperidínu ako antagonistu nmda receptora, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje | |
SK284167B6 (sk) | Derivát arylalkylpyridazinónu, spôsob jeho prípravy, použitie derivátu arylalkylpyridazinónu, farmaceutický prostriedok, ktorý ho obsahuje, a spôsob prípravy farmaceutického prostriedku | |
EP1572646A1 (de) | N-(indolethyl-)cycloamin-verbindungen | |
CZ292379B6 (cs) | Tetrahydrochinolinové deriváty, způsob jejich výroby a farmaceutický prostředek s jejich obsahem | |
SK282703B6 (sk) | Benzoxazinónový derivát, jeho použitie a farmaceutický prostriedok na jeho báze | |
TW401417B (en) | 4-Aryloxy- and 4-arylthiopiperidine derivatives | |
US5602144A (en) | Thienopyridones | |
US5714502A (en) | Piperidinylmethyloxazolidinones | |
KR20020027502A (ko) | 피페리딘 알콜 | |
US3316276A (en) | N-(3-pyrrolidinyl)-phthalimide derivatives | |
NZ206305A (en) | Benzazepine and benzodiazepine derivatives and pharmaceutical compositions | |
IE64349B1 (en) | New benzopyrrolidinone derivatives a process for the preparation therof and pharmaceutical compositions containing them |